Sale of Securities

Cadrenal Therapeutics, Inc. Filed 2026-06-15 Acc 0001628280-26-043385

Documents 1

2026-06-18 4 Chairman, CEO and Interim CFO sold 4,126 shares at an average $3.18 ($13,110)
2026-06-18 8-K Regulation FD disclosure · Other events
2026-06-15 144 Sale of Securities
2026-06-15 4 Chairman, CEO and Interim CFO sold 18,124 shares at an average $3.88 ($70,352)
2026-06-10 4 Chairman, CEO and Interim CFO sold 22,385 shares at an average $4.17 ($93,294)
2026-05-11 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…